Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings

Benzinga

08/11

Owens & Minor, Inc. (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.

Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens & Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.

On June 5, Owens & Minor announced it terminated its Rotech Healthcare acquisition.

Owens & Minor shares rose 12.4% to close at $7.09 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.
JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.
UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.

Considering buying OMI stock? Here’s what analysts think:

Read This Next:

Should You Buy Boeing? Jim Cramer Weighs In

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2558342886"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2558342886\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2558342886?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-11 15:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2558342886","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings","media":"Benzinga","content":"<html><body><p><strong>Owens &amp; Minor, Inc.</strong> (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.</p>\n<p>Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens &amp; Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On June 5, Owens &amp; Minor announced it terminated its Rotech Healthcare acquisition.</p>\n<p>Owens &amp; Minor shares rose 12.4% to close at $7.09 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.</li>\n</ul>\n<p>Considering buying OMI stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"518\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164.png 1106w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Should You Buy Boeing? Jim Cramer Weighs In</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2025-08-11 15:11</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong>Owens &amp; Minor, Inc.</strong> (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.</p>\n<p>Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens &amp; Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On June 5, Owens &amp; Minor announced it terminated its Rotech Healthcare acquisition.</p>\n<p>Owens &amp; Minor shares rose 12.4% to close at $7.09 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.</li>\n</ul>\n<p>Considering buying OMI stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"518\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164.png 1106w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Should You Buy Boeing? Jim Cramer Weighs In</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMI","symbol_name":"歐麥斯-麥能醫療","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47023978/top-wall-street-forecasters-revamp-owens-minor-expectations-ahead-of-q2-earnings","article_id":"2558342886","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2558342886","pubTimestamp":1754896284,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OMI":"欧麦斯-麦能医疗"},"translate_title":"华尔街顶级预测师在第二季度财报公布前修改了欧文斯和米诺的预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMI":1},"content_text":"Owens & Minor, Inc. (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.\nAnalysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens & Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.\nOn June 5, Owens & Minor announced it terminated its Rotech Healthcare acquisition.\nOwens & Minor shares rose 12.4% to close at $7.09 on Friday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nBaird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.\nJP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.\nUBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.\n\nConsidering buying OMI stock? Here’s what analysts think: \n\nRead This Next: \n\nShould You Buy Boeing? Jim Cramer Weighs In\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}